General Peptide Discussion

More Research Use Only peptide companies are starting to announce that they are “moving into telehealth,” “partnering with doctors,” or plan

For anyone who has tried both GHK-Cu and NAD+ , what differences did you notice between them? I’m mainly curious about the injection-site fe

Just got off my klow cycle and have been running glutathione for 4 weeks now. Would starting on epithalon and mots be a good move in helping

Hello everyone, I would like to start a discussion regarding potential synergistic effects between Retatrutide GLP‑1/GIP/glucagon triple‑rec

I'm Currently on Reta but I want to get off. I'm taking it to balance the insulin resistance. Not using it for weight loss. Im at the age wh

One thing I honestly did not account for when building this community was how many people on TikTok are getting involved with PEPs without r

I been trying PT-141 and I didn't feel anything at .5mg. I went up at 1mg and I got flushed and my face got red..lol. I tried at .7mg and I

Looking back, there are a few things I would’ve done differently. My top three: 1. I would’ve shared vials with my husband. 😂 We were resea

Over the past several months, one of the biggest changes I’ve noticed while watching VialTalk grow is how much the peptide market itself is

I just hit my 2 months using Reta and NAD+ and down 25 lbs with little to no working out other than my kids keeping me busy. It’s been great

I’ve been going down the ADAMAX rabbit hole recently because I’ve been looking into adding it to my research library — but before doing that

Please list every company that is that you see that is gouging the consumers us so I can expose them anywhere possible whether it’s TikTok I

Hi I'm Savannah , founder of BioGlow . I am really excited to be a vendor here on Vial Talk . This is an incredible platform that FINALLY al

I currently am trying to understand the different milligrams, different doses, the different types of glutathione The 600-1200 and 1500 mill

The market is moving in two very different directions right now. On one side, we are seeing more vendors move toward heavier testing, full-p

I chose HGH over tesamorelin while cutting with retatrutide because I wanted something more direct and consistent, especially with my schedu

The peptide space looks different than it did even a year ago. Some observations. GLP-1 went mainstream. Semaglutide and tirzepatide changed